Navigating the Modern Landscape of Sepsis: Advances in Diagnosis and Treatment
Open Access
- 5 July 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (13) , 7396
Abstract
Sepsis poses a significant threat to human health due to its high morbidity and mortality rates worldwide. Traditional diagnostic methods for identifying sepsis or its causative organisms are time-consuming and contribute to a high mortality rate. Biomarkers have been developed to overcome these limitations and are currently used for sepsis diagnosis, prognosis prediction, and treatment response assessment. Over the past few decades, more than 250 biomarkers have been identified, a few of which have been used in clinical decision-making. Consistent with the limitations of diagnosing sepsis, there is currently no specific treatment for sepsis. Currently, the general treatment for sepsis is conservative and includes timely antibiotic use and hemodynamic support. When planning sepsis-specific treatment, it is important to select the most suitable patient, considering the heterogeneous nature of sepsis. This comprehensive review summarizes current and evolving biomarkers and therapeutic approaches for sepsis.Keywords
Funding Information
- 2-Year Research Grant of Pusan National University
This publication has 315 references indexed in Scilit:
- Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19JAMA, 2021
- Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin LevelJAMA, 2018
- Enhancing Recovery From SepsisJAMA, 2018
- Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014JAMA, 2017
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Mortality Related to Severe Sepsis and Septic Shock Among Critically Ill Patients in Australia and New Zealand, 2000-2012JAMA, 2014
- Immunosuppression in Patients Who Die of Sepsis and Multiple Organ FailureJAMA, 2011
- Early Use of Polymyxin B Hemoperfusion in Abdominal Septic ShockJAMA, 2009
- Interferon Gamma-1b in the Treatment of Compensatory Anti-inflammatory Response SyndromeArchives of internal medicine (1960), 1997
- Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis SyndromeJAMA, 1994